BM

(redirected from biomarker)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia.
AcronymDefinition
BMBowel Movement
BMBlack Male
BMBeli Manastir, Croatia (automobile code)
BMBatman
BMBritish Museum
BMBurning Man
BMMyanmar (assumed name of Burma)
BMBookmark
BMBeam
BMBlack Metal (music genre)
BMBanco Mundial (Spanish: World Bank)
BMBundesministerium (Federal Ministry, Austria)
BMBob Marley
BMBone Marrow
BMBasement Membrane
BMBurma
BMBusiness Management
BMBlack Magic
BMBrian May (guitarist)
BMBlue Moon
BMBridesmaid
BMBenchmarking
BMBismarck
BMBanque Mondiale (French: World Bank)
BMBreast Milk
BMBiomarker
BMBlue Mountain (railroad)
BMBusiness Machines
BMBushmaster
BMBackground Music
BMBeatmania (DJ simulator game)
BMBig Mouth
BMBloody Mary
BMBaumeister (German: manager of building projects)
BMBusiness Manager
BMBrigada Militar (south Brazilian military police)
BMBig Mac
BMBachelor of Music (degree)
BMBallistic Missile(s)
BMBeastMaster (Utopia game)
BMBaby Mama (2008 movie)
BMBill Maher (comedian)
BMBeast Machines
BMBill Murray (actor)
BMBarry Manilow (musician)
BMBlademaster (gaming)
BMBirth Mother
BMBench Mark
BMBeautiful Music (broadcast radio format)
BMBehavior Modification
BMBe Mine
BMBack Matter
BMBirthmark
BMBoilermaker
BMBallymena (UK)
BMBritish Midland (Airline)
BMBOINC (Berkeley Open Infrastructure for Network Computing) Manager
BMBirmingham Midshires (building society bank, UK)
BMBanca Mondiale (Italian)
BMBite Me
BMBill of Material
BMBending Moment
BMBattle Management
BMBuild Margin
BMBurst Mode
BMBlack Mage (gaming)
BMBus Mastering
BMBachelor of Medicine
BMBad Manners
BMBrewmaster (gaming)
BMBasal Metabolism
BMBasilar Membrane
BmBaader-Meinhof (German terrorists)
BMBirlesmis Milletler (Turkish: United Nations )
BMBundesverband Mediation (German: Federal Mediation Association)
BMBeats Me
BMBishop Museum (Honolulu, HI)
BMBeer Money
BMBilly Mays (William Darrell Mays; 1958-2009)
BMBoatswains Mate
BMBlue Merle
BMBureau of Mines
BMBeachmaster
BMBull Moose (political party)
BMBaby's Mother
BMBlueberry Muffin (various applications)
BMBlue Mage (gaming)
BMBrick & Mortar (as opposed to existence exclusively on the Internet)
BMBoard Measure
BMBuilding Manager
BMBelgian Malinois
BMBook to Market (stocks)
BMBirthday Message
BMBus Monitor
BMBuffer Map (computer science)
BMBlonde Moment
BMBaseball Mogul (baseball simulation computer game)
BMBattery Machines
BMBreakdown Maintenance
BMBloodmage (gaming character)
BMBella Morte (band)
BMBody Mounted
BMBus Mouse
BMBehavioral Modeling
BMBrigade Major (Staff Officer to Brigade Commander)
BMBrain Man (TV series)
BMBronze Metal
BMBituminous Macadam (transportation engineering)
BMBattlefield Management
BMBroadcast Management
BMBluff Master (Indian film)
BMBattlespace Management
BMBerlekamp-Massey (algorithm)
BMBanyak Maunya (Indonesian: I Wish a Lot)
BMBrazilian Male
BMBeautiful Midnight (Matthew Good Band album)
BMBack Marker
BMBurger Machine (Philippine fast food chain)
BMBluff Me (gaming, World of Warcraft)
BMBible Museum
BMBeatae Memoriae (Latin: Of Blessed Memory)
BMBattlemac (gaming clan)
BMBound Mode
BMBitch Magnet (band)
BMBolliger & Mabillard (roller-coaster maker)
BMBase Movement
BMBastard Machine (band)
BMBoo Mansion (forum/website)
BMBazaar Malay
BMBranch on Minus
BMBurning Metro (band)
BMBridgemonkeys (gaming clan)
BMBriefing Message
BMBranch Material
BMBearing Mean
BMBrogan Maintenance (military slang)
BMBalanced Measure
BMBoston and Maine Railroad Corporation
BMBranch on Mixed (IBM)
BMBounding Method
BM(USN Rating) Boatswain's Mate
BMBakis Model (speech recognition)
References in periodicals archive ?
Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence of cancer, advancements in omics technologies, increasing healthcare expenditure, growth in R and D funding from government and private bodies, and rising demand for personalized medicine in cancer therapies.
Biomarkers of Translational Medicine: Safety, PK/PD, & Efficacy
The cost of follow-up tests should be relatively low, there should be proven treatment to modify the biomarker.
A large number of companies with varying technical backgrounds are involved in biomarkers and 294 of these are profiled in part 2 of the report with classification into various categories.
The concept of a biomarker capable of predicting plaque rupture is appealing.
The chapter on technology covers many different platforms for detecting biomarkers.
From a predictive modelling perspective, it is the variability in the outcome explained by a biomarker that is more important than the decimal point of the P value (6,7).
While these benefits are important, in reality, many individual biomarkers may never provide a definitive answer linking exposure to disease.
On the basis of technology, the biomarkers market is categorized into safety biomarkers, efficacy biomarkers, and validation biomarkers.
Another key finding from the report is that, across the cost-conscious EU5, the monitoring of expensive oncology agents' prescribing is increasing, and as more biomarker-agents become available, biomarker test results are likely to be included in this monitoring as well.
Successful proposals must 1) address biomarkers that are measured in biological media; an actual disease end point is not considered to be a biomarker of effect; 2) focus on one of the following emphasis areas: the reproductive system, the brain/nervous system, the immune system, or the respiratory system; 3) link the biomarker(s) to a toxic end point through an observation of a statistical relationship between the marker and the end point or through a link to a mechanism of action (key precursor event); 4) be relevant or related to environmental exposures; and 5) consider, as much as possible, issues of validation, robustness, and capacity for high-throughput applications.
Cyclacel Limited, the UK-based biopharmaceutical company, has demonstrated through state-of-the-art biomarker technology that CYC202 (R-roscovitine), its lead CDK inhibitor drug candidate, appears to induce cancer cell suicide or apoptosis in patients receiving the drug.